 | • レポートコード：MRC2203A012 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の血小板市場規模が、年平均3％成長すると予測しています。本市場調査レポートでは、血小板の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（血小板機能障害、血友病、血小板減少症、周術期疾患）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の血小板市場規模：用途別（血小板機能障害、血友病、血小板減少症、周術期疾患） ・世界の血小板市場規模：エンドユーザー別（病院、外来手術センター、その他） ・世界の血小板市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（The American National Red Cross、America's Blood Centers、Blood Centers of America、…） ・市場機会・将来傾向 |
The blood platelets market is projected to register a CAGR of more than 3% during the forecast period.
The COVID-19 pandemic is an unprecedented health concern that has impacted the blood platelets market. The onset of the COVID-19 pandemic has led several blood donation organizations to introduce safety guidelines pertaining to the donation of blood. For instance, in July 2020, the World Health Organization (WHO) introduced interim guidance on maintaining a safe and adequate blood supply during the COVID-19 pandemic. Moreover, countries worldwide are facing a shortage of blood donors. For instance, as per an article by The Lancet Hematology, the percentage of donors fell by 30% in 2020 at the Canadian Blood Services. Hence, several organizations, such as the American Association of Blood Banks (AABB), the American Blood Centers (ABC), and the American Red Cross, issued a joint statement in May 2020, which urged the public to donate blood during the pandemic. Such initiatives for blood donation may meet the demand for blood platelets by healthcare facilities in the pandemic.
The studied market growth can be largely attributed to the factors, such as the increasing prevalence of chronic blood-related disorders and the rising number of surgical procedures. These factors have created significant demand for blood platelets over the years and may continue to do so in the future.
With the increasing prevalence of chronic blood-related disorders, such as myelofibrosis, hemophilia, and thrombocytopenia, there is an increased demand for blood platelets. According to the 2019 Annual Global Survey by the World Federation of Hemophilia, approximately 324,648 people were identified with bleeding disorders out of 5.5 billion people, worldwide. Additionally, liver disorder patients are more often at risk of platelet reduction. For instance, as per a 2021 article by the Centers for Disease Control and Prevention (CDC), 4.5 million adults are diagnosed with liver disorders in the United States in 2018. Moreover, as per a 2021 article by the World Gastroenterology Organization (WHO), liver cirrhosis was one of the leading causes of death in 2020. Thus, the increasing prevalence of these disorders is projected to boost the demand for blood platelets treatment via hematopoietic stem cell transfer or transfusion methods.
The increasing number of surgical procedures, worldwide, is contributing to the increasing demand for blood platelets. Similarly, an increase in the number of orthopedic and cardiac surgeries is contributing to the rising demand for blood platelets in hospitals. Additionally, an increase in organ transplantations has boosted the demand for blood platelets. For instance, as per the Global Observatory on Donation and Transplantation data, 153,863 organs were transplanted annually in 2019, which was a 4.8% increase from 2018. Moreover, an increase in the number of trauma surgeries by impact forces, such as accidents, falls, sports, and crush injuries, is projected to boost the demand for blood platelets in the coming years. For instance, as per the 2021 statistics by the World Health Organization (WHO), each year, 20-50 million people suffer from non-fatal road injuries. Such a huge number indicates the rising need for blood platelets in these populations. Thus, all the factors mentioned above are currently augmenting the growth of the blood platelets market.
However, shortage of blood donors, risk of infections, and high cost of the surgeries are a few factors that restrain the market growth.
Key Market Trends
Platelet Function Disorders Segment is Expected to Witness a Significant CAGR Over the Forecast Period
Based on applications, platelet function disorders are predicted to witness significant growth. The major factors owing to the growth of the segment are the increasing prevalence of cancer. Chronic myelogenous leukemia and multiple myeloma cancers lead to the development of acquired platelet function disorders in some cancer patients. Therefore, cancer patients must undergo platelet transfusions frequently. As per the American Cancer Society estimates, approximately 34,920 people are likely to be diagnosed with multiple myeloma in 2021 in the United States. Additionally, as per the 2021 statistics by Cancer Research UK, incidence rates for myeloma are projected to increase by 11% in the United Kingdom between 2014 and 2035. Such numbers indicate the rising demand for platelet transfusion in the treatment of cancer patients. Moreover, chronic platelet function disorders contribute to the increasing demand for platelet transfusion. Thus, the administration of platelets in such patients is frequently performed in order to mitigate complications, including RBC requirements, surgical blood loss, and reoperation for bleeding. Thus, due to the factors mentioned above, the segment is anticipated to grow significantly over the forecast period.
North America Accounted for the Largest Share in the Global Market
In North America, the United States held a major share of the blood platelets market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. This is majorly attributed to the factors, such as the presence of several organizations engaged in the distribution of blood components. Moreover, these organizations in the region are engaged in increasing awareness regarding the importance of blood donation that is increasing the number of blood donors in the region. For instance, according to the 2020 statistics by the Centers for Disease Control and Prevention (CDC), presently, there are more than 13.2 million blood donors in the United States. Additionally, the number of platelet transfusions in the region has boosted the demand for blood platelets. For instance, as per the 2021 statistics by The American National Red Cross, approximately 21 million blood components are transfused each year in the United States. Thus, in view of the factors mentioned above, the blood platelets market is anticipated to grow significantly over the forecast period in North America.
Competitive Landscape
The blood platelets market is moderately competitive, and a few companies are currently dominating the market. These companies include Blood Centers of America, the American National Red Cross, Canadian Blood Services, Cellphire Inc., and PlateletBio, among others. The competition in the market is majorly based on the provision of blood components by these companies. Additionally, key players have been involved in organizing blood donation drives, campaigns, blood supply services to meet the demand from ambulatory surgical centers and hospitals with a focus on the expansion of blood platelet collection to secure the position in the global market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Number of Surgical Procedures
4.2.2 Increasing Prevalence of Chronic and Blood-related Disorders
4.3 Market Restraints
4.3.1 High Cost and Risk of Infections in Transfusion Procedure
4.3.2 Shortage of Blood Donors
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Applications
5.1.1 Platelet Function Disorders
5.1.2 Hemophilia
5.1.3 Thrombocytopenia
5.1.4 Perioperative Indications
5.2 By End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Other End Users
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 The American National Red Cross
6.1.2 America’s Blood Centers
6.1.3 Blood Centers of America
6.1.4 American Association of Blood Banks (AABB)
6.1.5 Canadian Blood Services
6.1.6 Cellphire Inc.
6.1.7 The European Blood Alliance
6.1.8 DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH
6.1.9 OneBlood
6.1.10 Megakaryon Corporation
6.1.11 PlateletBio
7 MARKET OPPORTUNITIES AND FUTURE TRENDS